Nickan Research Institute Journal of Parathyroid Disease 2345-6558 13 1 2025 01 01 Administration of cinacalcet in pediatric patients with CKD; a short-review on recent concepts e12269 e12269 10.34172/jpd.2025.12269 EN Sayed Yousef Mojtahedi https://orcid.org/0000-0002-6231-2662 Paniz Pourpashang https://orcid.org/0000-0003-4469-086X Journal Article 10.34172/jpd.2025.12269 2024 09 04 2024 12 28 Cinacalcet shows promise in treating secondary hyperparathyroidism (sHPT) in both pediatric and adult chronic kidney disease (CKD) populations; however, its efficacy appears more pronounced in adults. Pediatric patients face unique challenges that can hinder treatment success, necessitating careful monitoring and individualized approaches to therapy. Further research is essential to optimize dosing strategies and improve outcomes for children receiving cinacalcet.